Objective: To characterize and further compare the immune cell populations of the tumor microenvironment (TME) in both clear cell and papillary renal cell carcinoma (RCC) using heavy metal-labeled ...

Metastatic papillary renal cancer has poor outcomes, and new treatments are needed. There is a strong rationale for investigating the combination of mesenchymal epithelial transition receptor (MET) ...

In this video, Francesca Jackson-Spence,MBChB, BSc, shares data from the study, “Final overall survival and new ctDNA analysis in MET-driven advanced papillary renal cancer (CALYPSO; NCT02819596),” ...

The combination of savolitinib and durvalumab demonstrated durable activity in a phase 2 trial of patients with papillary RCC.

A Waukesha County deputy is battling a "rare, aggressive cancer." Steve Lyles has been with the department for nearly 20 ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

The three most common forms of RCC are clear cell RCC, papillary RCC and chromophobe RCC. Metabolic dysregulation in the development of clear cell renal cell carcinoma (ccRCC) remains to be ...

Patient 1 was a 73-year-old woman with a 30-year history of nephrolithiasis, as well as a history of rheumatoid arthritis and arterial hypertension. She had been treated with methotrexate ...

Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 LITESPARK-003 data.

This study aimed to establish relations between calcified deposits in renal papillae and the development and morphology of corresponding COM papillary renal calculi.